APA (7th ed.) Citation

Kawasuji, H., Tsuji, Y., Miyaki, K., Aoyama, T., Kurosaki, F., Ezaki, M., . . . Yamamoto, Y. (2025). High feasibility of salivary therapeutic drug monitoring in linezolid, but lower feasibility in tedizolid: A single-dose study in healthy subjects and a monocentric prospective exploratory study in patients who received linezolid. Journal of antimicrobial chemotherapy, 80(8), 2080. https://doi.org/10.1093/jac/dkaf169

Chicago Style (17th ed.) Citation

Kawasuji, Hitoshi, et al. "High Feasibility of Salivary Therapeutic Drug Monitoring in Linezolid, but Lower Feasibility in Tedizolid: A Single-dose Study in Healthy Subjects and a Monocentric Prospective Exploratory Study in Patients Who Received Linezolid." Journal of Antimicrobial Chemotherapy 80, no. 8 (2025): 2080. https://doi.org/10.1093/jac/dkaf169.

MLA (9th ed.) Citation

Kawasuji, Hitoshi, et al. "High Feasibility of Salivary Therapeutic Drug Monitoring in Linezolid, but Lower Feasibility in Tedizolid: A Single-dose Study in Healthy Subjects and a Monocentric Prospective Exploratory Study in Patients Who Received Linezolid." Journal of Antimicrobial Chemotherapy, vol. 80, no. 8, 2025, p. 2080, https://doi.org/10.1093/jac/dkaf169.